In this study, we used a combination of approaches that included sequencing the coding regions to identify common missense variation, and haplotype-based analyses to characterize common patterns of genetic variation across each locus to test the hypothesis that genetic variations in PRL and PRLR are associated with plasma PRL levels and breast cancer risk. The gene discussed is PRL; the disease is breast carcinoma.